Viemed Healthcare, Inc. $VMD Shares Acquired by First Eagle Investment Management LLC

First Eagle Investment Management LLC lifted its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 7.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 455,344 shares of the company’s stock after acquiring an additional 30,000 shares during the quarter. First Eagle Investment Management LLC’s holdings in Viemed Healthcare were worth $3,146,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of VMD. GSA Capital Partners LLP boosted its position in Viemed Healthcare by 497.7% during the first quarter. GSA Capital Partners LLP now owns 149,791 shares of the company’s stock worth $1,090,000 after purchasing an additional 124,731 shares in the last quarter. Nuveen LLC acquired a new position in shares of Viemed Healthcare during the 1st quarter worth approximately $787,000. Segall Bryant & Hamill LLC raised its stake in shares of Viemed Healthcare by 252.1% during the 1st quarter. Segall Bryant & Hamill LLC now owns 130,229 shares of the company’s stock worth $948,000 after buying an additional 93,242 shares during the period. Strs Ohio purchased a new position in shares of Viemed Healthcare during the 1st quarter valued at approximately $443,000. Finally, Jane Street Group LLC acquired a new stake in Viemed Healthcare in the 1st quarter valued at $394,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Insider Transactions at Viemed Healthcare

In related news, VP Jerome Cambre sold 4,880 shares of the stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $7.32, for a total value of $35,721.60. Following the completion of the sale, the vice president owned 84,191 shares of the company’s stock, valued at approximately $616,278.12. This trade represents a 5.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Michael Moore sold 50,090 shares of Viemed Healthcare stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.33, for a total value of $367,159.70. Following the transaction, the president owned 126,343 shares in the company, valued at approximately $926,094.19. The trade was a 28.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 20.00% of the stock is currently owned by corporate insiders.

Viemed Healthcare Stock Performance

Shares of NASDAQ:VMD opened at $6.37 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.13 and a quick ratio of 1.37. Viemed Healthcare, Inc. has a 1 year low of $5.93 and a 1 year high of $9.77. The firm has a market capitalization of $242.19 million, a PE ratio of 19.30 and a beta of 1.29. The business’s 50 day moving average price is $6.76 and its 200-day moving average price is $6.78.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. Viemed Healthcare had a return on equity of 9.95% and a net margin of 5.34%.The company had revenue of $71.91 million for the quarter, compared to analyst estimates of $72.00 million. Viemed Healthcare has set its FY 2025 guidance at EPS.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Viemed Healthcare in a research report on Tuesday, October 14th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, Viemed Healthcare presently has an average rating of “Hold”.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.